Steris Plc (STE31) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2023, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Steris Plc  (NYSE: STE31)
 

Steris Plc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Steris Plc inventory turnover ratio, the Steris Plc's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 4.39 in the second quarter 2026, yet the ratio remained below the average, as STE31's market remain challenging.Average inventory processing period, for the Steris Plc in Sep 30 2026 quarter, has decreased to 83 days, compare to 89 days, in the Jun 30 2026 quarter.

Within Healthcare sector 119 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form in the first quarter 2026, to 1116.

STE31 Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Steris Plc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

STE31 Inventory Turnover Ratio (Sep 30 2026)
II. Quarter		 (Jun 30 2026)
I. Quarter		 (Dec 31 2022)
III. Quarter		 (Sep 30 2022)
II. Quarter		 (Jun 30 2022)
I. Quarter
Y / Y Inventory Growth 18.79 % 23.84 % 82.5 % 14.24 % 4.61 %
Y / Y Cost of Sales Growth 51.92 % 26.53 % -5.46 % -15.07 % 6.58 %
Inventory Turnover Ratio (TTM) 4.39 4.12 4.07 4.63 5.02
STE31's Total Ranking # 1116 # # # #
Average inventory processing period 83 89 90 79 73
Seq. Inventory Growth 3.5 % 23.84 % -10.84 % 3.95 % 7.9 %
Seq. Cost of Sales Growth 8.56 % 27.49 % 4.21 % 5.33 % -9.58 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 29
Healthcare Sector # 120
Overall Market # 1116

Inventory Turnover Ratio Statistics
High Average Low
9.66 6.63 4.07
(Dec 31 2019)   (Dec 31 2022)



STE31 Company Profile >> Back to STE31 Efficiency Comparisons >> Compare STE31 Inventory Turnover Ratio to its Competitors

Financial Statements
Steris Plc's Inventories $ 737 Millions Visit STE31's Balance sheet
Steris Plc's Cost of Revenues TTM $ 2,929 Millions Visit STE31's Income Statement
What are STE31's Sales? Visit STE31's Sales by Segment

Other Inventory Turnover Ratios
Steris Plc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
STE31's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for STE31's Competitors
Inventory Turnover Ratio for STE31's Suppliers
Inventory Turnover Ratio for STE31's Customers

You may also want to know
STE31's Sales Growth Rates STE31's Pe Price to earnings ratio STE31's Receivables Turnover Ratio STE31's Stock Quote
STE31's Net Income Growth Rates STE31's Ps Price to Sales ratio STE31's Sales per Employee STE31's Asset Turnover Ratio
STE31's Net Margin STE31's Pb Price to Book ratio STE31's Financial Strength Ratios STE31's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Tarsus Pharmaceuticals Inc   10.68 $ 49.325  Millions$ 5  Millions
Sotera Health Company  10.25 $ 558.509  Millions$ 54  Millions
Lantheus Holdings Inc   9.76 $ 604.826  Millions$ 62  Millions
Vanda Pharmaceuticals Inc   8.70 $ 14.704  Millions$ 2  Millions
Phathom Pharmaceuticals Inc   7.76 $ 53.106  Millions$ 7  Millions
Novavax inc   7.03 $ 90.533  Millions$ 13  Millions
Carlisle Companies Incorporated  6.99 $ 3,406.400  Millions$ 488  Millions
Cardiff Lexington Corporation  6.98 $ 3.768  Millions$ 1  Millions
Carlsmed Inc   6.91 $ 15.844  Millions$ 2  Millions
Caredx Inc   6.42 $ 111.106  Millions$ 17  Millions
Edap Tms Sa  6.14 $ 60.833  Millions$ 10  Millions
Transmedics Group Inc   5.70 $ 301.220  Millions$ 53  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Myomo Inc   4.58 $ 14.802  Millions$ 3  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Autolus Therapeutics Plc  4.34 $ 88.293  Millions$ 20  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
Electromed Inc   4.18 $ 14.878  Millions$ 4  Millions
Intelligent Bio Solutions Inc   4.14 $ 2.206  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Sonoma Pharmaceuticals Inc   3.90 $ 14.275  Millions$ 4  Millions
Koru Medical Systems Inc   3.88 $ 16.831  Millions$ 4  Millions

Date modified: 2026-11-06T13:03:20+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.